Biotech Breakthroughs vs Governance Scandals: Hong Kong's Niche Stock DivideGlobal Report·Oct 21, 2026 at 09:16 AM013930.00%02181+1.02%
Mabpharm FY26 H1 profit more than doubled to RMB 31.36 million; revenue rises 45.1% to RMB 397.94 millionPUBT·Aug 28, 2026 at 01:05 PM02181+1.02%
Hong Kong Market Wrap: Kaisa's Windfall and Jingrui's Liquidation Highlight Sector ExtremesGlobal Report·Aug 5, 2026 at 09:12 AM016380.00%02181+1.02%
"MABPHARM" achieved a net profit of 57.13 million RMB for the entire year, turning a loss into a profitAASTOCKS·Mar 26, 2026 at 02:27 PM02181+1.02%
Hong Kong Stock Movement Quick Report: QUANTGROUP surged 22.28%, FIT HON TENG and XXF rose over 10%HK Stock Alerts·Mar 18, 2026 at 04:00 AM02685-7.56%01759+1.68%
Hong Kong Stock Movement Quick Report: BRIGHT SMART and MOBVISTA surged over 20%, while DEEPEXI TECH plummeted 17%HK Stock Alerts·Mar 13, 2026 at 03:00 AM01428-0.58%01860-4.28%
Insiders the biggest winners as Mabpharm Limited's (HKG:2181) market cap rises to HK$2.3bSimplywall·Jan 10, 2026 at 12:38 AM02181+1.02%